Top Policy Experts to Debate Link Between Rising Health Care Costs and Advances in Medical Technology, Wednesday, April 16, 2008, From 8:30 - 10:00 A.M., at DC's National ... ( CBO Director Orszag CMS Administr...)

HOME >> MEDICINE >> NEWS

Top Policy Experts to Debate Link Between Rising Health Care Costs and Advances in Medical Technology, Wednesday, April 16, 2008, From 8:30 - 10:00 A.M., at DC's National Press Club

Date:4/15/2008

CBO Director Orszag, CMS Administrator Weems, Congressman Gene Green Among High-Level Panelists to Examine One of the Biggest Cost Drivers in Health Care At U.S. News & World Report Breakfast

WASHINGTON, April 15 /PRNewswire-USNewswire/ -- The following is being issued by U.S. News & World Report:

EVENT TOPIC: "HEALTH CARE AND TECHNOLOGY: Cost vs. Value"

DESCRIPTION: U.S. News & World Report's National Issues Briefing, in association with Siemens Healthcare, will examine the "value paradigm" between advances in technology and rising health care costs. The Briefing will consider the more frequent use of imaging in initial clinical evaluation, cost effectiveness and accessibility as well as early lessons in deploying health technology and what the industry can expect to deliver in the near future. The panel will also explore practical ways in which government and the health care industry can create standards for measuring new technologies, ensuring both quality of procedures and innovation while reducing costs.

WELCOME: Thomas Miller, CEO, Workflow and Solutions, Siemens Healthcare Sector (confirmed)

MODERATOR: Bernadine Healy, M.D., Health Editor, U.S. News & World Report (confirmed)

PANEL: Carolyn M. Clancy, M.D., Director, Agency for Healthcare Research and Quality (confirmed)

The Honorable Gene Green (D-TX), U.S. House of Representatives; Member, Subcommittee on Health (Energy & Commerce) (confirmed)

Judd E. Hollander, M.D., Professor, Clinical Research Director, University of Pennsylvania; President, Society for Academic Emergency Medicine (confirmed)

Hala Moddelmug, President and CEO, Susan G. Komen for the Cure (confirmed)

Peter R. Orszag, Director, Congressional Budget Office (confirmed)

Kerry N. Weems, Acting Administrator, Centers for Medicare and Medicaid Services (confirmed)

DATE: WEDNESDAY, APRIL 16, 2008

TIME: 8:30 a.m. - 10:00 a.m. (
'/>"/>

SOURCE U.S. News & World Report
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Susan G. Komen for the Cure(R) Calls on Policymakers to Address Unfairness in Breast Cancer Incidence and Mortality
2. Rochester Medical Applauds Improved U.S. Medicare Coverage Policy for Intermittent Catheters
3. Mens Health Policy Center Hosts Petition to Protest Government Barrier to Prostate Cancer Medications
4. Food Policy Institute primer on food imports and regulations
5. Transplant Societies Protest FDA Policy in American Journal of Transplantation
6. New Brain Fitness Training Promotes Health and Independence of Long Term Care Insurance Policyholders
7. Kidney Care Partners Encourages Policymakers to Support Increased Kidney Care Education and Disease Prevention Programs
8. Hope In Action: Policymakers and Artists Promote Youth and Latino Suicide Prevention
9. Student Pugwash USA launches science policy election guide for young voters
10. AXA Equitable Meets the Needs of Two People under One Life Insurance Policy
11. Asthma Foundation Appoints Award-Winning Scholar to Top Policy Position

Post Your Comments:

(Date:12/3/2009)...rn causes demand for affordable drug and alcohol r... sharp increase in demand for its services and att... led to an increase in alcoholic binge drinking, d... (PRWEB) December 3, 2009 -- Mountainside ...spike in demand for its services due to the econom...

(Date:12/3/2009)... of screening test, researcher says, , ...rch points to the possibility of a genetic link be...h high blood pressure who had a gene variant that ...d to be twice as likely as those without the varia...nd. , The finding may lead to a way to identify...

(Date:12/3/2009)...ewswire-USNewswire/ -- The American Association fo...rom one of the largest studies to date on passive ...e Northern California Cancer Center (NCCC) . ,...d cigarettes and who were exposed to secondhand ci...dulthood--had a significantly increased breast can...

(Date:12/3/2009)...PRNewswire-USNewswire/ -- The Board of Trustees of...mously voted to elect three new members during its... is co-founder and Managing Director of De Novo Ve...650 million from three funds in early stage medica...ded Medicus Venture Partners in 1989. He has inves...

(Date:12/3/2009)... For California,s 3.4 million owne...remains one of the most significant threats to not...o their business,s viability. ,, "As the reces...ners of small businesses are recognizing the need ...ed disability coverage," said Michael Hagedorn, ...

Breaking Medicine News(10 mins):Health News:Economic Crisis Causes Acute Demand for Affordable Drug Addiction Treatment 2 Health News:Vitamin D May Be Tied to Heart Disease Via Genes 2 Health News:Northern California Cancer Center's Findings on Breast Cancer and Secondhand Smoke Released Internationally by the American Association for Cancer Research 2 Health News:Salk Institute Board of Trustees Elects Leaders in Venture Capital and Publishing to its Membership 2 Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 2 Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 3 Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 4

[0] Economic Crisis Causes Acute Demand for Affordable Drug Addiction Treatment [0] Vitamin D May Be Tied to Heart Disease Via Genes [2] Northern California Cancer Center's Findings on Breast Cancer and Secondhand Smoke Released Internationally by the American Association for Cancer Research [0] Salk Institute Board of Trustees Elects Leaders in Venture Capital and Publishing to its Membership [1] New Disability Income Insurance Options Provide More Choice for California's Small Business Owners

...ealth Status; Anthem Blue Cross and Blue, Shield p...more than 5,000, Kentuckians located in the easte...LLE, Ky., Nov. 14 Anthem Blue Cross and Blue,Shie...tate. Anthem has assembled a dedicated team to col...

...s first diagnosed in childhood , , WEDNESD...be 87 years old, but he still remembers the day ...1925. , "I went to the hospital at five years of a...aid Cleveland, of Syracuse, N.Y. , He didn,t die....

...f frustration from,those who live with the risk of...tudies suggest that the comprehensive and often co...ming diabetes patients to the point,of inaction. S...ss of incorporating a complete diabetes management...

...uarter Ended September 30, 2007 ...348 Average Patient Charge (APC) ... uncompensated care as a percent of gross revenue .../Metro,Corporation (Nasdaq: RURL ), a leading pro...

...rug development platform, SEATTLE, Nov. 14 Analy... the progress and prospects of three of Cell,Thera...IC) oncology drug,candidates, as well as informati...Strategies, New Opportunities",in New York on Frid...

...tal, the nation,s,largest and most experienced den...Award from Benefits Selling magazine as the dental... design and network availability. The,awards were ...rences in eight categories that are determined to,...

Anthem Blue Cross and Blue Shield in Kentucky Announces Release of State Health Index A Full and Long Life, Despite Diabetes Natural Antioxidants Help Reduce Oxidative Stress in Diabetes Treatment Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline Brokers Name Delta Dental the Best in Coverage, Plan Design and Networks

(Date:12/3/2009)..., ALISO VIEJO, Calif. and STATE COLLEGE, Pa., Dec...s today announced the signing of an agreement to p...sing SoftGenetics, NextGENe software for next-gene..., (Logo: http://www.newscom.com/cgi-bin/prnh/... Ambry,s CSO said, "Our team at Ambry has been pro...

(Date:12/3/2009)... , DOYLESTOWN, Pa., Dec. 3 /PRNewswire-FirstCa... Corporation, (Nasdaq: QGLY ) www.quigleyco.com ...s evaluation of its opportunities to develop presc...ncluded that it is in its best interests to focus ...ich may include but are not limited to its Cold-EE...

(Date:12/3/2009)..., WILMINGTON, Del., Dec. 3 Parag...rmaceutical risk management and optimal medication...9, on the FDA,s draft guidance on REMS - Risk Eval...ications for REMS lifecycle management. Dr. Gary ...expert on REMS and risk management programs, will ...

Breaking Medicine Technology:Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2 Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3 Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2 Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3 Photo 3A Stopain and the Arthritis Foundation Join Forces to Promote the Benefits of Staying Active 54192 1 Photo 3A Stopain and the Arthritis Foundation Join Forces to Promote the Benefits of Staying Active 54192 2 Prime Therapeutics 2009 Drug Trend Insights Shows Drug Spending Slows to Lowest Rate on Record 54189 1 Prime Therapeutics 2009 Drug Trend Insights Shows Drug Spending Slows to Lowest Rate on Record 54189 2 Prime Therapeutics 2009 Drug Trend Insights Shows Drug Spending Slows to Lowest Rate on Record 54189 3 Ranbaxy Receives Final Approval To Market Sumatriptan Succinate Tablets 54186 1 Ranbaxy Receives Final Approval To Market Sumatriptan Succinate Tablets 54186 2

[0] Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects [0] Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution [0] Webinar to Explore FDA Draft REMS Guidance and Its Implications for Lifecycle Management

...te phase III trial - , , SOUTH SAN FRANCISCO, Cal...nnounced top-line results from their phase II stud...ders. The data was presented on March 27th at the...ican College of Medical Genetics by Brendan Lee, M...igator and Professor Department of Molecular and H...

... in combination with the most commonly used doses ...tients with mixed dyslipidemia , , ORLANDO, Fla.,...tt ,s TRILIPIX(R) (fenofibric acid) delayed-releas...m met all of the study,s primary endpoints. TRILI...m 5 mg significantly improved HDL cholesterol and ...

Other Medicine Technology:Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders 2 Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders 3 Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders 4 New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management 2 New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management 3 New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management 4 New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management 5

Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management

...eye protection Properly manufactured radiation pr...f scatter radiation. Our high quality frames and m...h minimized weight. Our lenses are made of Schott ... standards. Most Pulse Glasses are offered with le...

...re designed with the safety and comfort of the pra...lso called SF-6) leaded glass, the industry standa...t standards, as set for optical clarity, visible l...While our eyewear is protecting your eyes, it also...

Glasses,metal,trifocal

Medicine Products:

Wrap Metal Standard Wrap Around Frame Glasses,metal,trifocal

Top Policy Experts to Debate Link Between Rising Health Care Costs and Advances in Medical Technology, Wednesday, April 16, 2008, From 8:30 - 10:00 A.M., at DC's National ...( CBO Director Orszag CMS Administr...),Health